Metrogyl DG Forte Gel is a topical antimicrobial formulation containing Chlorhexidine Gluconate (0.5% w/w) and Metronidazole (1.5% w/w), designed for the treatment of various oral infections and periodontal conditions. Chlorhexidine Gluconate acts as a broad-spectrum antiseptic, effectively reducing bacterial load by disrupting microbial cell membranes, while Metronidazole provides potent activity against anaerobic bacteria and protozoa, commonly implicated in periodontal diseases. This synergistic combination makes Metrogyl DG Forte Gel particularly effective in managing gingivitis, periodontitis, and other inflammatory conditions of the oral cavity. The gel base ensures prolonged contact with the mucosal surfaces, enhancing drug retention and therapeutic efficacy. It is indicated for adjunctive use alongside mechanical debridement procedures to improve clinical outcomes in dental plaque control and infection management. Metrogyl DG Forte Gel is generally well tolerated, with minimal risk of systemic absorption, reducing the likelihood of systemic side effects. Patients should apply the gel as directed by a dental professional, typically twice daily, avoiding ingestion. Caution is advised in patients with known hypersensitivity to chlorhexidine or metronidazole. Overall, Metrogyl DG Forte Gel offers a targeted, effective approach to controlling oral microbial infections and promoting periodontal health.